Roongroj Bhidayasiri (Richard)
Professor & Neurologist
Chulalongkorn University
Professor Bhidayasiri graduated in medicine from Chulalongkorn University, Thailand, in 1993, receiving membership of the Royal College of Physicians of London and Ireland in 1998 and certified by the American Board of Psychiatry and Neurology in 2005. He was awarded the fellowship of the Royal College of Physicians of London in 2008 and the Royal College of Physicians of Ireland in 2010.
Professor Bhidayasiri leads a Parkinson’s disease registry in Thailand in collaboration with the Thai Red Cross society, the Ministry of Public Health, Bangkok Metropolitan and the National Health Security Office of Thailand and establishes Chulalongkorn Centre of Excellence for Parkinson’s Disease as the only tertiary centre dedicated to Parkinson’s disease and related disorders in affiliation with the Thai Red Cross Society. In addition to his role as a clinician and fellowship program director, his research interest is in data science from objective monitoring and assisted devices in Parkinson’s disease. He co-develops devices for tremor and nocturnal monitoring as well as a glove for tremor suppression. His development of an adjustable laser-guided walking stick has been adopted nationwide by the Ministry of Social Development and Human Security of Thailand for patients with freezing of gait.
He serves as the associate editor of Journal of Parkinson’s Disease, section editor of the journal Parkinsonism and Related Disorders, is an editorial board member of the Journal of Neurological Sciences, as well as a writing committee panel member of the American Academy of Neurology on the practice parameters of tardive syndromes. Recently, he has been selected as a member of the Academy of Science of the Royal Society of Thailand. Professor Bhidayasiri is currently a chair of the Asian-Oceanian section of the International Parkinson and Movement Disorder Society (MDS).
Roland Dominic G. Jamora
Neurologist
University of the Philippines Manila
Dr. Jamora finished his Adult Neurology at the Philippine General Hospital, serving as the chief resident. He pursued further training at the National Neuroscience Institute in Singapore under Prof Louis Tan and Prof EK Tan.
He is a consultant neurologist of the Philippine General Hospital, Cardinal Santos Medical Center, and St. Luke’s Medical Center. He was a past president of the Movement Disorder Society of the Philippines and has served the International Parkinson and Movement Disorder Society in various capacities.
He has been publishing articles on general neurology and movement disorders. At present, he is pursuing his PhD in Health Sciences at the University of the Philippines Manila.
Olivier Rascol
Professor & Neurologist
Toulouse University Hospital
Doctor Olivier Rascol is a neurologist specialized in Movement Disorders, Professor of Clinical Pharmacology at the Toulouse University Hospital since 1993. He obtained his MD in Neurology (Toulouse, 1985) and his PhD in Neurosciences (Paris, 1992). Dr Rascol is running the Toulouse Clinical Investigation Centre since 1994 and the Toulouse European Space Clinic since 1998. He is the coordinator of the Toulouse Expert Center for Parkinson Disease and of the French Reference Center for Multiple System Atrophy (Atypical Parkinsonism). Dr Rascol is the chair of the NS-Park/F-CRIN Neurosciences Network on clinical research in Parkinson disease since 2010. From 2011, Dr Rascol is now coordinating the National French Clinical Research Infrastructure Network F-CRIN.
As a neuropharmacologist, Dr Rascol’s main fields of interest are Parkinson’s disease and movement disorders, drug development for Parkinson’s disease and functional neuroimaging. Dr Rascol has been actively involved in the development of several marketed antiparkinsonian medications (ropinirole, rasagiline, entacapone, safinamide, pramipexole ER, amantadine ER). He is currently running several research programs for disease progression and symptomatic management of PD (motor signs, dyskinesias and on-off problems, non-motor signs such as pain and sleep problems) with new dopaminergic (dopamine agonists, dopamine reuptake inhibitors, MAO-B inhibitors…) and non-dopaminergic (serotonergic, glutamatergic, …) drugs in collaboration with several academic and industry research centres in the US and in Europe. He is acting in this field as an external advisor for French and European scientific organisations, patients’ associations, drug agencies and international pharmaceutical companies. As the chair of the National F-CRIN Clinical Research infrastructure, Dr Rascol has been deeply involved within the last few years in the management and organisation of clinical research in France.
Dr Rascol is member of several French and American neurological and pharmacological societies. He was the Secretary of the international Movement Disorders Society (2006-2009) and the chair of the MDS-ES (2013-2015) and is a member of the WFN Research Committee on Parkinsonism and Related Disorders. Dr Rascol is working or has worked as associate-editor for the Journal Fundamental and Clinical Pharmacology and the Movement Disorder Journal and is or has been a member of the editorial board of Lancet Neurology, Neurology, the European Journal of Neurology, the Evidence Medicine.
Dr Rascol has published more than 500 articles in International Scientific journals (New England Journal of Medicine, Lancet, Lancet neurology, Annals of Neurology, Neurology, Archives of Neurology, Brain, Movement Disorders…). His H factor is 94. He has also been invited to give more than 450 lectures in various European, North and South American and Asian universities or national and international meetings.